-

ONT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Onterris, Inc. (ONT)

Onterris guided full-year 2026 revenue to $840 million-$900 million in February and reiterated that range in May. On August 5, 2026, the Company cut it to $740 million-$790 million and shares fell approximately 18%.

NEW YORK--(BUSINESS WIRE)--A guidance reduction of roughly $105 million at the midpoint sent Onterris, Inc. (NYSE: ONT) shares down approximately 17.5% to 18% on August 5, 2026. Shareholders who lost money on ONT are encouraged to have their losses reviewed now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

The February 25, 2026 guidance assumed annual environmental emergency response revenue of $50.0 million to $70.0 million. On the February 26, 2026 call, CEO Vijay Manthripragada stated that organic revenue growth of "7% to 9% remains our long-term expectation. And for 2026, we expect to be at the high end of that range." On May 6, 2026, the Company stated the "[r]evenue guidance range of $840.0 million to $900.0 million is unchanged."

Q2 2026 revenue came in at $186.7 million, down 20.4% year over year. Management attributed the shortfall primarily to unusually low emergency response and recovery activity, and also cited lower pass-through revenue and temporary regulatory waivers affecting some air-testing work. Onterris also disclosed a Board strategic review. Levi & Korsinsky is investigating potential securities law violations concerning these guidance statements.

If you purchased Onterris shares and suffered a loss, submit your ONT loss information here. You may also reach Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.

Levi & Korsinsky, LLP | Top 50 Securities Firm | (212) 363-7500 | www.zlk.com

Frequently Asked Questions About the ONT Investigation

Q: Who is eligible to participate in the ONT investigation? A: Investors who purchased ONT stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses -- not on whether you still hold the shares.

Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Onterris, Inc. made materially false or misleading statements regarding its full-year 2026 revenue guidance and organic growth expectations.

Q: How much did ONT stock drop? A: Shares fell approximately 18% after the Company reported Q2 revenue of $186.7 million and cut full-year revenue guidance by roughly $105 million at the midpoint. Investors who suffered losses may be eligible to seek recovery.

Q: What do ONT investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at jlevi@levikorsinsky.com or (212) 363-7500.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my ONT shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought ONT and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost to participate. Securities investigations and any resulting actions are generally handled on a contingency basis -- no retainer and no out-of-pocket costs.

Q: What if I live outside the United States? A: U.S. securities fraud investigations generally cover purchases on U.S. exchanges regardless of the investor's country of residence.

Attorney Advertising. Prior results do not guarantee similar outcomes.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

Levi & Korsinsky, LLP

NYSE:ONT

Release Versions

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171

More News From Levi & Korsinsky, LLP

TENX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Tenax Therapeutics (TENX)

NEW YORK--(BUSINESS WIRE)--A single clinical readout drove Tenax Therapeutics (NASDAQ: TENX) shares down approximately 84% to 85% shareholder after the Company disclosed that its Phase 3 LEVEL trial of TNX-103 in PH-HFpEF missed both its primary and key secondary endpoints. If you held TENX shares and suffered a loss, you are encouraged to click here to submit your information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. The...

CRTO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Criteo (CRTO)

NEW YORK--(BUSINESS WIRE)--Criteo S.A. (NASDAQ: CRTO) shareholders were told in May to expect flat to low-single-digit growth in full-year Contribution ex-TAC; on August 5, 2026, the Company cut that figure to a decline of 10% to 12% at constant currency, and shares fell sharply. If you lost money on Criteo stock, you are encouraged to click here to submit your information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. The time...

SION Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Sionna Therapeutics (SION)

NEW YORK--(BUSINESS WIRE)--Roughly 90% of Sionna Therapeutics (SION) market value was erased after the Company released Phase 2a PreciSION CF results for SION-719, representing a decline of approximately $40 per share from the stock’s recent trading levels. If you held SION shares and suffered a loss, you are encouraged to click here to submit your information. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. The impact on shareho...
Back to Newsroom